Psilocybin, the primary psychoactive compound in magic mushrooms, remains to be a federally-managed Schedule I drug; this means that psilocybin mushrooms are deemed to own no medically recognized use and have a superior potential for abuse. But FDA-accepted trials for the designated breakthrough therapy keep on just after reports located psilocybin